Evidence map›Paper›PMID 21607119›Full record

ArticleCoordination chemistry reviews2011

Pterin chemistry and its relationship to the molybdenum cofactor.

Partha Basu, Sharon J N Burgmayer

Abstract read
In one paragraph

Article in Coordination chemistry reviews, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed.

  1. Article
  2. Semiartificial COChemical reviews · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Identifying Biomarkers for Chronic Obstructive Pulmonary Disease in the Salivary Metabolome.International journal of chronic obstructive pulmonary disease · 2026
    Article
  7. Article
  8. Article
  9. Hydrogen Bond-Assisted PCET and Formation of WAngewandte Chemie (International ed. in English) · 2025
    Article
  10. Article
  11. Pushing at the Boundaries of Pterin Chemistry.Molecules (Basel, Switzerland) · 2024
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. The History of the Molybdenum Cofactor-A Personal View.Molecules (Basel, Switzerland) · 2022
    Review
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Partha BasuDepartment of Chemistry and Biochemistry, Duquesne University, Pittsburgh, PA 15282, United States.
Sharon J N Burgmayer

Funding

MODELS OF NITRATE REDUCTASES AND RELATED ENZYMESR15GM061555 · NIGMS · DUQUESNE UNIVERSITY · PI BASU, PARTHA · 2000 to 2015
$1.4M
Molybdenum Pterin-Dithiolene Complexes for Model Studies of the Catalytic Site ofR15GM081848 · NIGMS · BRYN MAWR COLLEGE · PI BURGMAYER, SHARON NIETER · 2007 to 2014
$496k
NIGMS NIH HHS R15 GM061555NIGMS NIH HHS R15 GM081848
6 · The paper itself

Abstract

The molybdenum cofactor is composed of a molybdenum coordinated by one or two rather complicated ligands known as either molybdopterin or pyranopterin. Pterin is one of a large family of bicyclic N-heterocycles called pteridines. Such molecules are widely found in Nature, having various forms to perform a variety of biological functions. This article describes the basic nomenclature of pterin, their biological roles, structure, chemical synthesis and redox reactivity. In addition, the biosynthesis of pterins and current models of the molybdenum cofactor are discussed.

Identifiers

PMID21607119
PMCPMC3098623

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.